Table 4.
Group C (n = 50) | Group E (n = 50) | P-value | |
---|---|---|---|
FG(mmol/L, mean ± SD) | |||
Pre 1d | 5.2 ± 0.9 | 5.2 ± 0.7 | 0.666 |
Pos 1d | 7.4 ± 1.2* | 6.7 ± 1.2* | 0.010 |
FINS(mU/L, mean ± SD) | |||
Pre 1d | 7.6 ± 1.4 | 7.5 ± 1.7 | 0.706 |
Pos 1d | 10.8 ± 1.9* | 9.6 ± 2.2* | 0.005 |
Homa-IR (mean ± SD) | |||
Pre 1d | 1.8 ± 0.6a | 1.8 ± 0.6a | 0.609 |
Pos 1d | 3.6 ± 1.2* | 3.0 ± 1.2* | 0.007 |
Homa-IS (M(P25, P75)) | |||
Pre 1d | 0.5(0.4,0.8)a | 0.6(0.5,0.8)a | 0.605 |
Pos 1d | 0.3(0.2,0.4)* | 0.4(0.3,0.5)* | 0.018 |
Homa-β (M(P25, P75)) | |||
Pre 1d | 81.0(67.2,173.2)a | 89.5(75.9,117.3)a | 0.504 |
Pos 1d | 58.4(50.0,61.1)* | 60.9(53.4,66.8)* | 0.045 |
FG Fasting glucose, FIns Fasting insulin, HOMA-IR Homeostasis model assessment-insulin resistance index, HOMA-IS Homeostasis model assessment-insulin sensitivity index, HOMA-β Homeostasis model assessment-β; Pre 1d Preoperative day 1, Pos 1d Postoperative day 1, SD Standard deviation, M Median, P Percentile
P-value indicates the statistical difference between the two groups at the same time point
*Indicates a statistically significant difference compared with Pre 1d, P < 0.05
aIndicates values that were not subject to normal distribution (ManneWhitney U test)